Structure-activity relationship studies on 4''-O-acyltylosin derivatives: significance of their 23-O-mycinosyl and 4''-O-acyl moieties in antimicrobial activity against macrolide-resistant microbes. 1989

K Kiyoshima, and M Sakamoto, and H Nomura, and T Yoshioka, and R Okamoto, and T Sawa, and H Naganawa, and T Takeuchi
Sanraku Inc., Central Research Laboratories, Fujisawa, Japan.

Essential roles for both the 23-O-mycinosyl and 4''-O-acyl moieties of 4''-O-acyltylosin derivatives in the expression of antimicrobial activity against multiple macrolide-resistant strains of Staphylococci and mycoplasmas were demonstrated by in vitro comparison of the MICs of erythromycin, josamycin, tylosin and its 3- and 4''-O-acyl derivatives, demycinosyltylosin (DMT) and its 3- and 4''-O-acyl derivatives and 23-modified 3-O-acetyl-4''-O-isovaleryl-DMT derivatives.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009174 Mycoplasma A genus of gram-negative, mostly facultatively anaerobic bacteria in the family MYCOPLASMATACEAE. The cells are bounded by a PLASMA MEMBRANE and lack a true CELL WALL. Its organisms are pathogens found on the MUCOUS MEMBRANES of humans, ANIMALS, and BIRDS. Eperythrozoon,Haemobartonella,Mycoplasma putrefaciens,PPLO,Pleuropneumonia-Like Organisms,Pleuropneumonia Like Organisms
D004352 Drug Resistance, Microbial The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS). Antibiotic Resistance,Antibiotic Resistance, Microbial,Antimicrobial Resistance, Drug,Antimicrobial Drug Resistance,Antimicrobial Drug Resistances,Antimicrobial Resistances, Drug,Drug Antimicrobial Resistance,Drug Antimicrobial Resistances,Drug Resistances, Microbial,Resistance, Antibiotic,Resistance, Drug Antimicrobial,Resistances, Drug Antimicrobial
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013210 Staphylococcus A genus of gram-positive, facultatively anaerobic, coccoid bacteria. Its organisms occur singly, in pairs, and in tetrads and characteristically divide in more than one plane to form irregular clusters. Natural populations of Staphylococcus are found on the skin and mucous membranes of warm-blooded animals. Some species are opportunistic pathogens of humans and animals.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015645 Tylosin Macrolide antibiotic obtained from cultures of Streptomyces fradiae. The drug is effective against many microorganisms in animals but not in humans. Fradizine,Tylan,Tylosin Hydrochloride,Tylosin Tartrate,Tylosin Tartrate (Salt),Tylosine,Hydrochloride, Tylosin,Tartrate, Tylosin

Related Publications

K Kiyoshima, and M Sakamoto, and H Nomura, and T Yoshioka, and R Okamoto, and T Sawa, and H Naganawa, and T Takeuchi
June 1982, The Journal of antibiotics,
K Kiyoshima, and M Sakamoto, and H Nomura, and T Yoshioka, and R Okamoto, and T Sawa, and H Naganawa, and T Takeuchi
March 2004, Planta medica,
K Kiyoshima, and M Sakamoto, and H Nomura, and T Yoshioka, and R Okamoto, and T Sawa, and H Naganawa, and T Takeuchi
March 2002, Planta medica,
K Kiyoshima, and M Sakamoto, and H Nomura, and T Yoshioka, and R Okamoto, and T Sawa, and H Naganawa, and T Takeuchi
May 1979, The Journal of antibiotics,
K Kiyoshima, and M Sakamoto, and H Nomura, and T Yoshioka, and R Okamoto, and T Sawa, and H Naganawa, and T Takeuchi
August 2020, Molecules (Basel, Switzerland),
K Kiyoshima, and M Sakamoto, and H Nomura, and T Yoshioka, and R Okamoto, and T Sawa, and H Naganawa, and T Takeuchi
October 2008, Bioorganic & medicinal chemistry letters,
K Kiyoshima, and M Sakamoto, and H Nomura, and T Yoshioka, and R Okamoto, and T Sawa, and H Naganawa, and T Takeuchi
June 1987, The Journal of antibiotics,
K Kiyoshima, and M Sakamoto, and H Nomura, and T Yoshioka, and R Okamoto, and T Sawa, and H Naganawa, and T Takeuchi
January 2000, Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic],
K Kiyoshima, and M Sakamoto, and H Nomura, and T Yoshioka, and R Okamoto, and T Sawa, and H Naganawa, and T Takeuchi
July 1985, Chemical & pharmaceutical bulletin,
K Kiyoshima, and M Sakamoto, and H Nomura, and T Yoshioka, and R Okamoto, and T Sawa, and H Naganawa, and T Takeuchi
April 2012, Marine drugs,
Copied contents to your clipboard!